2Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int, 1999,56:1627-1637.
3Kim SI, Han DC, Lee HB. Lovastatin inhibits transforming growth factor-β1 expression in diabetic rat glomeruli and cultured rat mesangial cells. J Am Soc Nephrol, 2000, 11:80-87.
4Reed MJ, Meszaros K, Entes LJ, et al. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of type Ⅱ diabetes. Diabetelogia, 1999,42:102-106.
5Katoh M, Kurosawa Y, Tanaka K, et al. Fluvastatin inhibits O2- and ICAM-1 levels in a rat model with aortic remodeling induced by pressure overload. Am J Physiol Heart Circ Physiol, 2001, 281: H655-660.
6Aoyama I, Shimokata K, Niwa T. An oral absorbent downregulates renal expression of genes that promote interstitial inflammation and fibrosis in diabetic rats. Nephron, 2002, 92: 635-651.
7Kwong KY, Literat A, Zhu NL, et al. Expression of transforming growth factor beta (TGF-beta1) in human epithelial alveolar cells: a pro-inflammatory mediator independent pathway. Life Sci, 2004, 74:2941-2957.
8Gilber RE, Cox A, Wu LL, et al. Expression of transforming growth factor-β and type Ⅳ collage in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition. Diabetes, 1998, 47: 414-421.
9Khwaja A, Connolly JO, Hendry BM. Prenylation inhibitors in renal disease. Lancet, 2000, 355:741-744.
10Liu ZH,Li YJ,Chen ZH,et al.Glucose transporter in human glomerular mesangial cells modulated by transforming growth factor-beta and rhein.Acta Pharmacol Sin,2001,22(2):169-175.
9Domhorst A, Liiddeke HJ, Sreenan S, et al. Safety and efficacy of in- sulin detemir in clinical practice:14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort [J]. Int J Clin Praet,2008,61 (3) :523 -528.
10Garber A, Henry R, Ratner R, et al. Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEADY3 Mono) :a randomised, 52week, phase Ⅲ, double-blind, parallel-treatment trial [ J ]. Lancet, 2009,373 (9662) :473 - 481.
